Clarus700 Brochure
Clarus700 Brochure
Clarus700 Brochure
Fluorescein angiograms with non-proliferative diabetic retinopathy, illustrating localized dilations of retinal capillaries
(microaneurysms) and areas of peripheral non-perfusion.
ZEISS CLARUS 700 is a truly comprehensive imaging system developed for eye care specialists,
helping deliver state-of-the-art care to their patients.
2
Montage fluorescein angiography with non-proliferative diabetic retinopathy, presenting the finest details at the
foveal avascular zone and offering an exceptional rendering of the smallest microaneurysms across the image–from
the fovea to the periphery.
COLOR
Capture True Color to assist with differential diagnosis.
CLARITY
See high-resolution details from the posterior pole to the periphery.
COMPLETE
Comprehensive in every way to maximize workflow efficiency.
3
Now, ultra-wide fundus imaging
with True Color and unmatched clarity.
In one complete system.
1
Data on file.
True Color with RGB Red channel: reveals the Green channel: provides Blue channel: increases Fluorescein
Channel Separation choroid in more detail. This excellent contrast of visibility of anterior retinal Angiography of
may be helpful in visualizing the retina, especially layers, allowing easier proliferative diabetic
choroidal lesions such as of vasculature and visualization of retinal nerve retinopathy
nevi or tumors. hemorrhages. fiber layers defects and
epiretinal membranes.
4
FAF-Green image FAF-Blue image of Stereo image pairs can be captured for External Eye
of dry age-related geographic atrophy stereoscopic evaluation of the fundus.
macular degeneration
5
True advancement in disease management.
By allowing you to visualize to the far periphery—and in multiple imaging modalities—
ZEISS CLARUS 700 can document indications of ocular disease that occur in various regions
of the eye and present differently depending on the imaging modality.
6
Macular Telangiectasia
Mid-phase fluorescein angiography image of an eye with macular telangiectasia. Wide-field fluorescein angiography captures
leakage in the macula, its associated microaneurysms and non-perfusion in the far temporal periphery.
Dry AMD
FAF-Green image of an eye with central geographic atrophy in advanced Dry AMD, highlighting the loss of retinal pigment
epithelium at the macula.
7
ZEISS CLARUS 700 ultra-wide fluorescein angiography shows you the extensive sea-fan neovascularization
and retinal ischemia in the peripheral retina in an eye with proliferative sickle cell retinopathy.
8
Integrated Diagnostic Imaging
platform from ZEISS.
See the whole picture.
Key to meeting current challenges in eye care is the ability to capture, integrate and
transform high-quality data into meaningful analyses that enhance practice workflow and
improve patient care.
The ZEISS Integrated Diagnostic Imaging combines exam data from gold-standard devices
like CLARUS ultra-widefield fundus imaging and CIRRUS ™ HD-OCT from ZEISS and presents
critical information from multiple sources into a single integrated point-of-view for more
efficient and insightful treatment decisions.
Retina Workplace
9
Advanced features to help you
capture your best images.
PrecisionFocus
Quickly see the details in regions of interest by selecting where to optimize focus,
without losing the macula focal point.
AutoBright
Spend time analyzing images rather than adjusting them. ZEISS CLARUS 700 automatically optimizes the
brightness of the image sequence throughout the angiogram, while still preserving the change in signal.
And with the extremely large dynamic range, you’ll never be at risk of saturating the image.
Original AutoBright
GazePoint
Find the patient’s gaze angle quickly
and accurately. CLARUS 700 uses AI to
automatically find the optic nerve head
and accurately derive the patient’s gaze
rather than relying on internal fixation.
10
Technical Specifications
CLARUS 700 from ZEISS
Parameters
Imaging Modes:
• True Color (with Red, Green and Blue channel split) • External eye image (ocular surface)
• Fluorescein Angiography • Stereo
• Autofluorescence-Green
• Autofluorescence-Blue
Resolution:
• Optical 7.3 µm
Minimum Pupil Diameter: 2.5 mm
Working Distance: 25 mm (patient’s eye to front lens)
Compensation for ametropia: - 24 D to + 20 D continuous
Light Sources:
• Red LED 585 - 640 nm
• Green LED 500 - 585 nm
• Blue LED 435 - 500 nm
• Infrared laser diode 785 nm
Instrument Specifications
Instrument Weight: 50 lbs (22.7 kg)
Instrument Dimensions (W x D x H): 15” (38.1 cm) x 18” (45.7 cm) x 27” (68.6 cm)
Instrument Table:
• Description Wheelchair accessible, electronic lift
• Table Dimensions 37” (94 cm) x 27.5” (70 cm)
• Weight 81 lbs (37 kg)
At-Instrument Computer
Monitor: 22” Full HD MVA LCD Touch Screen: Capacitive, Multi-Touch
with LED Backlight
Resolution: 1920 x 1080 RAM: 32GB
Processor: Intel ® 6th Generation Input/Output: USB 3.0 x 3; RS-232 x 2; 1.5 kV
Core i5-6500TE Isolated Gigabit Ethernet Port x 2;
HDMI; and DisplayPort
Hard Drive: 2 TB Operating System: Windows 10
(minimum 200,000 images)
Dimensions (W x D x H): 21.5” (54.6 cm) x 2.5” (6.4 cm) x 13.75” (34.9 cm)
Weight: 17.2 lbs (7.8 kg) Mounting: VESA 75/100 mm
11
USA
0297
CLARUS 700
Dublin, CA 94568
5160 Hacienda Drive
www.zeiss.com/us/med
Carl Zeiss Meditec, Inc.
www.zeiss.com/us/clarus700
GERMANY
07745 Jena
Carl Zeiss Meditec AG
www.zeiss.com/clarus700
Goeschwitzer Strasse. 51-52
Download the ZEISS Image Library App directly from the App Store.
www.zeiss.com/med/contacts
Explore a wide selection of modalities such as ultra-widefield and OCTA.
CAM.11445 CZ VII/2019 United States edition: Only for sale in selected countries.
The contents of the brochure may differ from the current status of approval of the product or service offering in your country. Please contact our regional representatives for
more information. Subject to changes in design and scope of delivery and due to ongoing technical development. CLARUS 700 and CIRRUS-HDD-OCT are either trademarks
or registered trademarks of Carl Zeiss Meditec AG or other companies of the ZEISS Group in Germany and / or other countries.
© Carl Zeiss Meditec, Inc., 2019. All rights reserved.